Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
4
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
4
×
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
astrazeneca
bristol-myers squibb
cancer immunotherapy
clinical trials
deals
merck
nonalcoholic steatohepatitis
pfizer
What
bio
drug
4
×
roundup
companies
nash
news
week
acquisitions
alzheimer’s
annual
approval
approved
assessed
attention
biggest
biogen’s
biopharmaceutical
biotech
build
buy
ceo
communities
company’s
conference
convo
daniel
debut
digital
disease
dyne’s
earlier
epidemic
esmo
europe
failures
fatty
fda
frenzied
germany
gilead
Language
unset
Current search:
cancer
×
startups
×
drug
×
abbvie
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More